Ketamine Rapidly Enhances Glutamate-Evoked Dendritic Spinogenesis in Medial Prefrontal Cortex Through Dopaminergic Mechanisms
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Background: Ketamine elicits rapid onset antidepressant effects in clinically depressed patients, through mechanisms hypothesized to involve the genesis of neocortical dendritic spines and synapses. Yet, the observed changes in dendritic spine morphology usually emerge well after ketamine clearance, raising questions about the link between rapid behavioral effects of ketamine and plasticity. Methods: Here, we use 2-photon glutamate uncaging/imaging to focally induce spinogenesis in the medial prefrontal cortex (mPFC), directly interrogating baseline and ketamine-associated plasticity of deep layer pyramidal neurons in C57BL/6 mice. We combine pharmacological, genetic, optogenetic, and chemogenetic manipulations to interrogate dopaminergic mechanisms underlying ketamine-induced rapid enhancement in evoked plasticity and associated behavioral changes. Results: We find that ketamine rapidly enhances glutamate-evoked spinogenesis in mPFC, with timing that matches the onset of its behavioral efficacy and precedes changes in dendritic spine density. Ketamine increases evoked cortical spinogenesis through Drd1 receptor activation that requires dopamine release, compensating blunted plasticity in a learned helplessness paradigm. The enhancement in evoked spinogenesis after Drd1 activation or ketamine treatment depends on postsynaptic Protein Kinase A (PKA) activity. Furthermore, ketamine’s behavioral effects are blocked by chemogenetic inhibition of dopamine release and mimicked by activating presynaptic dopaminergic terminals, or postsynaptic Gαs-coupled cascades in mPFC. Conclusions: Our findings highlight dopaminergic mediation of rapid enhancement in activity-dependent dendritic spinogenesis and behavioral effects induced by ketamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433 · cited 1×
“Because DA tone in the mPFC changes through the life span (79 – 82), the variance in ketamine ’ s antidepressant ef fi cacy [e.g., low ef fi cacy and more transient effects for geriatric depression (83)] may be partially explained by the age-related alterations in cortical DA tone.”
BackgroundDomingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 2×
“We found that 2 days of stressful experience is suf fi cient to decrease the potential of spinogenesis in mPFC pyramidal neurons, in contrast to changes in dendritic spine density that normally manifest after chronic stress (16,63,64).”
BackgroundDopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · cited 1×
“A recently published meta-analysis suggests that subanesthetic doses of ketamine increase DA levels in the PFC (43), reported for both in vivo and ex vivo studies (44 – 48).”
BackgroundSynaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Berridge, K. C., & Kringelbach, M. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.018 · Cited by 1,730
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Research works printed but not linked: 39
- Duman, 2018, Ketamine and rapid-acting antidepressants: A new era in the battle against depression and suicide, F1000Research, 7, 659, 10.12688/f1000research.14344.1 · DOI · Paper page
- Wray, 2019, NMDAR-independent, cAMP-dependent antidepressant actions of ketamine, Mol Psychiatry, 24, 1833, 10.1038/s41380-018-0083-8 · DOI · Paper page
- Gerhard, 2016, Emerging treatment mechanisms for depression: Focus on glutamate and synaptic plasticity, Drug Discov Today, 21, 454, 10.1016/j.drudis.2016.01.016 · DOI · Paper page
- Sarkar, 2016, Sex differences in effects of ketamine on behavior, spine density, and synaptic proteins in socially isolated rats, Biol Psychiatry, 80, 448, 10.1016/j.biopsych.2015.12.025 · DOI
- Krystal, 2013, Rapid-acting glutamatergic antidepressants: The path to ketamine and beyond, Biol Psychiatry, 73, 1133, 10.1016/j.biopsych.2013.03.026 · DOI · Paper page
- Krystal, 2019, Ketamine: A paradigm shift for depression research and treatment, Neuron, 101, 774, 10.1016/j.neuron.2019.02.005 · DOI · Paper page
- Luking, 2016, Reward processing and risk for depression across development, Trends Cogn Sci, 20, 456, 10.1016/j.tics.2016.04.002 · DOI · Paper page
- de Jong, 2019, A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system, Neuron, 101, 133, 10.1016/j.neuron.2018.11.005 · DOI · Paper page
- Lammel, 2014, Reward and aversion in a heterogeneous midbrain dopamine system, Neuropharmacology, 76, 351, 10.1016/j.neuropharm.2013.03.019 · DOI · Paper page
- Vander Weele, 2018, Dopamine enhances signal-to-noise ratio in cortical-brainstem encoding of aversive stimuli, Nature, 563, 397, 10.1038/s41586-018-0682-1 · DOI · Paper page
- Dailly, 2004, Dopamine, depression and antidepressants, Fundam Clin Pharmacol, 18, 601, 10.1111/j.1472-8206.2004.00287.x · DOI · Paper page
- Kokkinou, 2018, The effects of ketamine on dopaminergic function: Meta-analysis and review of the implications for neuropsychiatric disorders, Mol Psychiatry, 23, 59, 10.1038/mp.2017.190 · DOI · Paper page
- Verma, 1996, NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine, J Neurosci, 16, 373, 10.1523/JNEUROSCI.16-01-00373.1996 · DOI · Paper page
- Chatterjee, 2012, Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice, Neuropharmacology, 63, 1161, 10.1016/j.neuropharm.2012.05.041 · DOI
- Lindefors, 1997, Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex, Brain Res, 759, 205, 10.1016/S0006-8993(97)00255-2 · DOI · Paper page
- Lorrain, 2003, Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: Modulation by a group II selective metabotropic glutamate receptor agonist LY379268, Neuroscience, 117, 697, 10.1016/S0306-4522(02)00652-8 · DOI · Paper page
- Wang, 2001, D1 dopamine receptors potentiate NMDA-mediated excitability increase in layer V prefrontal cortical pyramidal neurons, Cereb Cortex, 11, 452, 10.1093/cercor/11.5.452 · DOI · Paper page
- Gulledge, 2001, Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex, J Neurophysiol, 86, 586, 10.1152/jn.2001.86.2.586 · DOI · Paper page
- Chen, 2007, Dopamine D1/5 receptor-mediated long-term potentiation of intrinsic excitability in rat prefrontal cortical neurons: Ca2+-dependent intracellular signaling, J Neurophysiol, 97, 2448, 10.1152/jn.00317.2006 · DOI · Paper page
- Kozorovitskiy, 2015, Neuromodulation of excitatory synaptogenesis in striatal development, eLife, 4, 10.7554/eLife.10111 · DOI
- Pologruto, 2003, ScanImage: Flexible software for operating laser scanning microscopes, Biomed Eng Online, 2, 13, 10.1186/1475-925X-2-13 · DOI · Paper page
- Coupé, 2012, A CANDLE for a deeper in vivo insight, Med Image Anal, 16, 849, 10.1016/j.media.2012.01.002 · DOI
- Guo, 2015, Dynamic rewiring of neural circuits in the motor cortex in mouse models of Parkinson’s disease, Nat Neurosci, 18, 1299, 10.1038/nn.4082 · DOI · Paper page
- Santana, 2009, Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex, Cereb Cortex, 19, 849, 10.1093/cercor/bhn134 · DOI · Paper page
- Waddington, 1986, Behavioural correlates of the action of selective D-1 dopamine receptor antagonists: Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems, Biochem Pharmacol, 35, 3661, 10.1016/0006-2952(86)90649-0 · DOI
- Chourbaji, 2005, Learned helplessness: Validity and reliability of depressive-like states in mice, Brain Res Protoc, 16, 70, 10.1016/j.brainresprot.2005.09.002 · DOI · Paper page
- Radley, 2008, Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex, J Comp Neurol, 507, 1141, 10.1002/cne.21588 · DOI · Paper page
- Fasano, 2013, Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors, Neuropharmacology, 67, 432, 10.1016/j.neuropharm.2012.11.030 · DOI · Paper page
- Stachniak, 2014, Chemogenetic synaptic silencing of neural circuits localizes a hypothalamus→midbrain pathway for feeding behavior, Neuron, 82, 797, 10.1016/j.neuron.2014.04.008 · DOI · Paper page
- Mahler, 2014, Designer receptors show role for ventral pallidum input to ventral tegmental area in cocaine seeking, Nat Neurosci, 17, 577, 10.1038/nn.3664 · DOI · Paper page
- Roth, 2016, DREADDs for neuroscientists, Neuron, 89, 683, 10.1016/j.neuron.2016.01.040 · DOI · Paper page
- Shen, 2008, Dichotomous dopaminergic control of striatal synaptic plasticity, Science, 321, 848, 10.1126/science.1160575 · DOI · Paper page
- Veilleux-Lemieux, 2013, Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats, J Am Assoc Lab Anim Sci, 52, 567
- Li, 2010, Dopaminergic modulation of cognition across the life span, Neurosci Biobehav Rev, 34, 625, 10.1016/j.neubiorev.2010.02.003 · DOI
- MacDonald, 2012, Aging-related increases in behavioral variability: Relations to losses of dopamine D1 receptors, J Neurosci, 32, 8186, 10.1523/JNEUROSCI.5474-11.2012 · DOI
- Bryant, 2019, Effects of repeated intravenous ketamine in treatment-resistant geriatric depression, J Clin Psychopharmacol, 39, 158, 10.1097/JCP.0000000000001006 · DOI
- Konietzny, 2017, Dendritic actin cytoskeleton: Structure, functions, and regulations, Front Cell Neurosci, 11, 147, 10.3389/fncel.2017.00147 · DOI · Paper page
- Bachmann, 2013, Reciprocal regulation of PKA and Rac signaling, Proc Natl Acad Sci U S A, 110, 8531, 10.1073/pnas.1215902110 · DOI
- Nagai, 2016, Phosphoproteomics of the dopamine pathway enables discovery of Rap1 activation as a reward signal in vivo, Neuron, 89, 550, 10.1016/j.neuron.2015.12.019 · DOI
Cited by
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Shao, L.-X., Liao, C., Gregg, I., Davoudian, P. A., Savalia, N. K., Delagarza, K., & Kwan, A. C. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.008 · Cited by 626
Towards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
“Finally, the enhanced spinogenesis induced by ketamine, which is also a psychoplastogen, has been associated with reductions in depression-related behaviors [117, 118].”
BackgroundNeuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276
The molecular pathophysiology of depression and the new therapeutics
Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122
Synaptic Mechanisms Regulating Mood State Transitions in Depression
Parekh, P. K., Johnson, S. B., & Liston, C. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-110920-040422 · Cited by 101
Metadata
- Authors
- Wu, M., Minkowicz, S., Dumrongprechachan, V., Hamilton, P., & Kozorovitskiy, Y.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 89
- Issue
- 11
- Pages
- 1096-1105
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W3118515300
- Cited by
- 95
- References
- 48
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Kinship Foundation
- National Institute of Mental Health (T32 AG20506)
- National Institute of Neurological Disorders and Stroke (R01NS107539)
- Arnold and Mabel Beckman Foundation
- Brain and Behavior Research Foundation
- Rita Allen Foundation
- American Heart Association (19PRE34380056)
- National Science Foundation (DGE-1842165)
- National Institutes of Health
- National Alliance for Research on Schizophrenia and Depression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine Rapidly Enhances Glutamate-Evoked Dendritic Spinogenesis in Medial Prefrontal Cortex Through Dopaminergic Mechanisms. https://app.cochat.ai/papers/10.1016/j.biopsych.2020.12.022
- The paper
- Wu, M., Minkowicz, S., Dumrongprechachan, V., Hamilton, P., & Kozorovitskiy, Y. (2021). Ketamine Rapidly Enhances Glutamate-Evoked Dendritic Spinogenesis in Medial Prefrontal Cortex Through Dopaminergic Mechanisms. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2020.12.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.